Selected research
Industry Research
Veterinary & Animal Vaccines Industry Research Report 2026
Market perspective
The global Veterinary & Animal Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary & Animal Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veterinary & Animal Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary & Animal Vaccines include Zoetis, Tianjin Ringpu, Merck Animal Health, Virbac, Vetoquinol, Phibro Animal Health, Idt Biologika, Hipra and Hester, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary & Animal Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary & Animal Vaccines Market by Company
Zoetis
Tianjin Ringpu
Merck Animal Health
Virbac
Vetoquinol
Phibro Animal Health
Idt Biologika
Hipra
Hester
Elanco
China Animal Husbandry
Boehringer Ingelheim
Biogenesis Bago
Veterinary & Animal Vaccines Segment by Type
Live Attenuated Vaccines
Toxoid Vaccines
Inactivated Vaccines
Recombinant Vaccines
Other Vaccines
Veterinary & Animal Vaccines Segment by Application
Hospitals and Clinics
Others
Veterinary & Animal Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary & Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary & Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary & Animal Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary & Animal Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary & Animal Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Attenuated Vaccines
- Toxoid Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Other Vaccines
Applications
- Hospitals and Clinics
- Others
Companies covered
- Zoetis
- Tianjin Ringpu
- Merck Animal Health
- Virbac
- Vetoquinol
- Phibro Animal Health
- Idt Biologika
- Hipra
- Hester
- Elanco
- China Animal Husbandry
- Boehringer Ingelheim
- Biogenesis Bago
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary & Animal Vaccines Market Size (2021-2032)
- 2.2.2 Global Veterinary & Animal Vaccines Sales (2021-2032)
- 2.2.3 Global Veterinary & Animal Vaccines Market Average Price (2021-2032)
- 2.3 Veterinary & Animal Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Live Attenuated Vaccines
- 2.3.3 Toxoid Vaccines
- 2.3.4 Inactivated Vaccines
- 2.3.5 Recombinant Vaccines
- 2.3.6 Other Vaccines
- 2.4 Veterinary & Animal Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals and Clinics
- 2.4.3 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary & Animal Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary & Animal Vaccines Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Veterinary & Animal Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary & Animal Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary & Animal Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary & Animal Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary & Animal Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Veterinary & Animal Vaccines, Established Date
- 3.9 Global Veterinary & Animal Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Veterinary & Animal Vaccines Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Tianjin Ringpu
- 4.2.1 Tianjin Ringpu Company Information
- 4.2.2 Tianjin Ringpu Business Overview
- 4.2.3 Tianjin Ringpu Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio
- 4.2.5 Tianjin Ringpu Recent Developments
- 4.3 Merck Animal Health
- 4.3.1 Merck Animal Health Company Information
- 4.3.2 Merck Animal Health Business Overview
- 4.3.3 Merck Animal Health Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Animal Health Veterinary & Animal Vaccines Product Portfolio
- 4.3.5 Merck Animal Health Recent Developments
- 4.4 Virbac
- 4.4.1 Virbac Company Information
- 4.4.2 Virbac Business Overview
- 4.4.3 Virbac Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Virbac Veterinary & Animal Vaccines Product Portfolio
- 4.4.5 Virbac Recent Developments
- 4.5 Vetoquinol
- 4.5.1 Vetoquinol Company Information
- 4.5.2 Vetoquinol Business Overview
- 4.5.3 Vetoquinol Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vetoquinol Veterinary & Animal Vaccines Product Portfolio
- 4.5.5 Vetoquinol Recent Developments
- 4.6 Phibro Animal Health
- 4.6.1 Phibro Animal Health Company Information
- 4.6.2 Phibro Animal Health Business Overview
- 4.6.3 Phibro Animal Health Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio
- 4.6.5 Phibro Animal Health Recent Developments
- 4.7 Idt Biologika
- 4.7.1 Idt Biologika Company Information
- 4.7.2 Idt Biologika Business Overview
- 4.7.3 Idt Biologika Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Idt Biologika Veterinary & Animal Vaccines Product Portfolio
- 4.7.5 Idt Biologika Recent Developments
- 4.8 Hipra
- 4.8.1 Hipra Company Information
- 4.8.2 Hipra Business Overview
- 4.8.3 Hipra Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hipra Veterinary & Animal Vaccines Product Portfolio
- 4.8.5 Hipra Recent Developments
- 4.9 Hester
- 4.9.1 Hester Company Information
- 4.9.2 Hester Business Overview
- 4.9.3 Hester Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hester Veterinary & Animal Vaccines Product Portfolio
- 4.9.5 Hester Recent Developments
- 4.10 Elanco
- 4.10.1 Elanco Company Information
- 4.10.2 Elanco Business Overview
- 4.10.3 Elanco Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Elanco Veterinary & Animal Vaccines Product Portfolio
- 4.10.5 Elanco Recent Developments
- 4.11 China Animal Husbandry
- 4.11.1 China Animal Husbandry Company Information
- 4.11.2 China Animal Husbandry Business Overview
- 4.11.3 China Animal Husbandry Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio
- 4.11.5 China Animal Husbandry Recent Developments
- 4.12 Boehringer Ingelheim
- 4.12.1 Boehringer Ingelheim Company Information
- 4.12.2 Boehringer Ingelheim Business Overview
- 4.12.3 Boehringer Ingelheim Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio
- 4.12.5 Boehringer Ingelheim Recent Developments
- 4.13 Biogenesis Bago
- 4.13.1 Biogenesis Bago Company Information
- 4.13.2 Biogenesis Bago Business Overview
- 4.13.3 Biogenesis Bago Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio
- 4.13.5 Biogenesis Bago Recent Developments
5 Global Veterinary & Animal Vaccines Market Scenario by Region
- 5.1 Global Veterinary & Animal Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary & Animal Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Veterinary & Animal Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Veterinary & Animal Vaccines Sales by Region: 2027-2032
- 5.3 Global Veterinary & Animal Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary & Animal Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary & Animal Vaccines Revenue by Region: 2027-2032
- 5.4 North America Veterinary & Animal Vaccines Market Facts & Figures by Country
- 5.4.1 North America Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary & Animal Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Veterinary & Animal Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Veterinary & Animal Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary & Animal Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary & Animal Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Veterinary & Animal Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary & Animal Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary & Animal Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary & Animal Vaccines Market Facts & Figures by Country
- 5.7.1 South America Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary & Animal Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Veterinary & Animal Vaccines Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Veterinary & Animal Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary & Animal Vaccines Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Veterinary & Animal Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Veterinary & Animal Vaccines Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Veterinary & Animal Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary & Animal Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary & Animal Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary & Animal Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary & Animal Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary & Animal Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Veterinary & Animal Vaccines Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Veterinary & Animal Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary & Animal Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary & Animal Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary & Animal Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary & Animal Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary & Animal Vaccines Value Chain Analysis
- 8.1.1 Veterinary & Animal Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary & Animal Vaccines Production Mode & Process
- 8.2 Veterinary & Animal Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary & Animal Vaccines Distributors
- 8.2.3 Veterinary & Animal Vaccines Customers
9 Global Veterinary & Animal Vaccines Analyzing Market Dynamics
- 9.1 Veterinary & Animal Vaccines Industry Trends
- 9.2 Veterinary & Animal Vaccines Industry Drivers
- 9.3 Veterinary & Animal Vaccines Industry Opportunities and Challenges
- 9.4 Veterinary & Animal Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst